221 related articles for article (PubMed ID: 21111731)
1. p190RhoGAP mediates protective effects of oxidized phospholipids in the models of ventilator-induced lung injury.
Birukova AA; Zebda N; Cokic I; Fu P; Wu T; Dubrovskyi O; Birukov KG
Exp Cell Res; 2011 Apr; 317(6):859-72. PubMed ID: 21111731
[TBL] [Abstract][Full Text] [Related]
2. Association between adherens junctions and tight junctions via Rap1 promotes barrier protective effects of oxidized phospholipids.
Birukova AA; Zebda N; Fu P; Poroyko V; Cokic I; Birukov KG
J Cell Physiol; 2011 Aug; 226(8):2052-62. PubMed ID: 21520057
[TBL] [Abstract][Full Text] [Related]
3. Tiam1 and betaPIX mediate Rac-dependent endothelial barrier protective response to oxidized phospholipids.
Birukova AA; Malyukova I; Mikaelyan A; Fu P; Birukov KG
J Cell Physiol; 2007 Jun; 211(3):608-17. PubMed ID: 17219408
[TBL] [Abstract][Full Text] [Related]
4. Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids.
Singleton PA; Chatchavalvanich S; Fu P; Xing J; Birukova AA; Fortune JA; Klibanov AM; Garcia JG; Birukov KG
Circ Res; 2009 Apr; 104(8):978-86. PubMed ID: 19286607
[TBL] [Abstract][Full Text] [Related]
5. Paxillin-beta-catenin interactions are involved in Rac/Cdc42-mediated endothelial barrier-protective response to oxidized phospholipids.
Birukova AA; Malyukova I; Poroyko V; Birukov KG
Am J Physiol Lung Cell Mol Physiol; 2007 Jul; 293(1):L199-211. PubMed ID: 17513457
[TBL] [Abstract][Full Text] [Related]
6. Interaction of p190RhoGAP with C-terminal domain of p120-catenin modulates endothelial cytoskeleton and permeability.
Zebda N; Tian Y; Tian X; Gawlak G; Higginbotham K; Reynolds AB; Birukova AA; Birukov KG
J Biol Chem; 2013 Jun; 288(25):18290-9. PubMed ID: 23653363
[TBL] [Abstract][Full Text] [Related]
7. Afadin controls p120-catenin-ZO-1 interactions leading to endothelial barrier enhancement by oxidized phospholipids.
Birukova AA; Fu P; Wu T; Dubrovskyi O; Sarich N; Poroyko V; Birukov KG
J Cell Physiol; 2012 May; 227(5):1883-90. PubMed ID: 21732359
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E receptor-4 receptor mediates endothelial barrier-enhancing and anti-inflammatory effects of oxidized phospholipids.
Oskolkova O; Gawlak G; Tian Y; Ke Y; Sarich N; Son S; Andreasson K; Bochkov VN; Birukova AA; Birukov KG
FASEB J; 2017 Sep; 31(9):4187-4202. PubMed ID: 28572443
[TBL] [Abstract][Full Text] [Related]
9. Oxidized phospholipids reduce ventilator-induced vascular leak and inflammation in vivo.
Nonas S; Birukova AA; Fu P; Xing J; Chatchavalvanich S; Bochkov VN; Leitinger N; Garcia JG; Birukov KG
Crit Care; 2008; 12(1):R27. PubMed ID: 18304335
[TBL] [Abstract][Full Text] [Related]
10. Polar head groups are important for barrier-protective effects of oxidized phospholipids on pulmonary endothelium.
Birukova AA; Fu P; Chatchavalvanich S; Burdette D; Oskolkova O; Bochkov VN; Birukov KG
Am J Physiol Lung Cell Mol Physiol; 2007 Apr; 292(4):L924-35. PubMed ID: 17158600
[TBL] [Abstract][Full Text] [Related]
11. Oxidized phospholipids protect against lung injury and endothelial barrier dysfunction caused by heat-inactivated Staphylococcus aureus.
Meliton AY; Meng F; Tian Y; Sarich N; Mutlu GM; Birukova AA; Birukov KG
Am J Physiol Lung Cell Mol Physiol; 2015 Mar; 308(6):L550-62. PubMed ID: 25575515
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of endothelial cell permeability by high and low doses of oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine.
Starosta V; Wu T; Zimman A; Pham D; Tian X; Oskolkova O; Bochkov V; Berliner JA; Birukova AA; Birukov KG
Am J Respir Cell Mol Biol; 2012 Mar; 46(3):331-41. PubMed ID: 21997484
[TBL] [Abstract][Full Text] [Related]
13. Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protection.
Birukova AA; Chatchavalvanich S; Oskolkova O; Bochkov VN; Birukov KG
Microvasc Res; 2007 May; 73(3):173-81. PubMed ID: 17292425
[TBL] [Abstract][Full Text] [Related]
14. Fragmented oxidation products define barrier disruptive endothelial cell response to OxPAPC.
Birukova AA; Starosta V; Tian X; Higginbotham K; Koroniak L; Berliner JA; Birukov KG
Transl Res; 2013 Jun; 161(6):495-504. PubMed ID: 23305708
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation.
Birukova AA; Zagranichnaya T; Fu P; Alekseeva E; Chen W; Jacobson JR; Birukov KG
Exp Cell Res; 2007 Jul; 313(11):2504-20. PubMed ID: 17493609
[TBL] [Abstract][Full Text] [Related]
16. Cross talk between paxillin and Rac is critical for mediation of barrier-protective effects by oxidized phospholipids.
Birukova AA; Alekseeva E; Cokic I; Turner CE; Birukov KG
Am J Physiol Lung Cell Mol Physiol; 2008 Oct; 295(4):L593-602. PubMed ID: 18676874
[TBL] [Abstract][Full Text] [Related]
17. Role of IQGAP1 in endothelial barrier enhancement caused by OxPAPC.
Tian Y; Tian X; Gawlak G; Sarich N; Sacks DB; Birukova AA; Birukov KG
Am J Physiol Lung Cell Mol Physiol; 2016 Oct; 311(4):L800-L809. PubMed ID: 27566003
[TBL] [Abstract][Full Text] [Related]
18. Anti-Inflammatory Effects of OxPAPC Involve Endothelial Cell-Mediated Generation of LXA4.
Ke Y; Zebda N; Oskolkova O; Afonyushkin T; Berdyshev E; Tian Y; Meng F; Sarich N; Bochkov VN; Wang JM; Birukova AA; Birukov KG
Circ Res; 2017 Jul; 121(3):244-257. PubMed ID: 28522438
[TBL] [Abstract][Full Text] [Related]
19. Dual role of vinculin in barrier-disruptive and barrier-enhancing endothelial cell responses.
Birukova AA; Shah AS; Tian Y; Moldobaeva N; Birukov KG
Cell Signal; 2016 Jun; 28(6):541-51. PubMed ID: 26923917
[TBL] [Abstract][Full Text] [Related]
20. A role for VEGFR2 activation in endothelial responses caused by barrier disruptive OxPAPC concentrations.
Birukova AA; Lee S; Starosta V; Wu T; Ho T; Kim J; Berliner JA; Birukov KG
PLoS One; 2012; 7(1):e30957. PubMed ID: 22303475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
